Follow us for updates
© 2022 reportr.world
Read the Story →

Worried Over Vaccine Effects? Duterte Certifies Compensation Bill as Urgent

To expedite passage.
by Arianne Merez
Feb 18, 2021
Photo/s: Presidential Photo
Shares

President Rodrigo Duterte has certified as urgent a bill seeking to form a compensation fund for Filipinos who experience adverse effects from COVID-19 vaccines, Malacañang said Thursday.

The certification will allow Congress to expedite the bill's passage since lawmakers no longer have to wait for three days before voting on it.

The bill seeks to provide for the formation of an indemnity fund to compensate persons who will receive COVID-19 jabs and would experience serious adverse side effects or even death.

ALSO READ:

Shot in the Arm: Why the COVAX Facility for Vaccines Matters

What First COVID-19 Vaccine in PH Means for Pandemic Leadership

COVID-19 vaccine czar Sec. Carlito Galvez Jr. earlier said an indemnity fund was needed as a requirement of COVID-19 vaccine makers given that the drugs will be used based on emergency use authorization.

This means that the vaccines are not yet licensed for commercial sale and are only for use during public health emergencies of international concern, like the COVID-19 pandemic.

ADVERTISEMENT - CONTINUE READING BELOW ↓

So far, the Philippines has yet to start its COVID-19 vaccination program which targets to inoculate some 70 million people this year.

ALSO READ:

Not for Sale: COVID-19 Vaccines for Emergency Use Only

Explained: How COVID Vaccines Get Fast-Tracked for Emergency Use

ADVERTISEMENT - CONTINUE READING BELOW ↓
Recommended Videos
Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.